- Home
- NAMS vs PBF Comparison
NAMS vs PBF Comparison
Compare NAMS & PBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- PBF
- Stock Information
- Founded
- NAMS 2019
- PBF 2008
- Country
- NAMS Netherlands
- PBF United States
- Employees
- NAMS N/A
- PBF N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- PBF Integrated oil Companies
- Sector
- NAMS Health Care
- PBF Energy
- Exchange
- NAMS Nasdaq
- PBF Nasdaq
- Market Cap
- NAMS 2.9B
- PBF 2.8B
- IPO Year
- NAMS N/A
- PBF 2012
- Fundamental
- Price
- NAMS $25.07
- PBF $23.28
- Analyst Decision
- NAMS Strong Buy
- PBF Hold
- Analyst Count
- NAMS 9
- PBF 13
- Target Price
- NAMS $41.00
- PBF $26.00
- AVG Volume (30 Days)
- NAMS 843.1K
- PBF 3.3M
- Earning Date
- NAMS 08-06-2025
- PBF 07-31-2025
- Dividend Yield
- NAMS N/A
- PBF 4.72%
- EPS Growth
- NAMS N/A
- PBF N/A
- EPS
- NAMS N/A
- PBF N/A
- Revenue
- NAMS $64,006,000.00
- PBF $30,275,300,000.00
- Revenue This Year
- NAMS N/A
- PBF N/A
- Revenue Next Year
- NAMS $73.09
- PBF $7.66
- P/E Ratio
- NAMS N/A
- PBF N/A
- Revenue Growth
- NAMS 762.15
- PBF N/A
- 52 Week Low
- NAMS $14.06
- PBF $13.62
- 52 Week High
- NAMS $27.29
- PBF $37.38
- Technical
- Relative Strength Index (RSI)
- NAMS 61.96
- PBF 50.23
- Support Level
- NAMS $24.73
- PBF $21.82
- Resistance Level
- NAMS $25.80
- PBF $23.10
- Average True Range (ATR)
- NAMS 1.33
- PBF 1.28
- MACD
- NAMS 0.17
- PBF -0.09
- Stochastic Oscillator
- NAMS 83.46
- PBF 45.95
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About PBF PBF Energy Inc.
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.